TJ Sharpe

Patient Engagement Program Manager, Medidata

T.J. Sharpe is a Stage IV melanoma patient diagnosed in August 2012 with tumors in multiple organs, undergoing six surgeries and four immunotherapies over two clinical trials. He is a writer, keynote speaker, and consultant to the biopharma/clinical research industries, bringing an educated patient voice to healthcare and drug development.